Polymorphisms in the ICAM gene locus are not associated with breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 1, 2006, Pages 178-179

  Cox, David G ^a   Hankinson, Susan E ^a,b   Hunter, David J ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 5; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; ICAM5 PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; GENETICS; RISK FACTOR;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MEMBRANE GLYCOPROTEINS; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 33645454794     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0790     Document Type: Article

References (5)

1. Kammerer S, Roth RB, Reneland R, et al. Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Res 2004;64:8906-10.
2. De Vivo I, Hankinson SE, Colditz GA, Hunter DJ. A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. Cancer Res 2003;63:5236-8.
3. Gauderman WJ. Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 2002;21:35-50.
4. O'Hanlon DM, Fitzsimons H, Lynch J, Tormey S, Malone C, Given HF. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer 2002;38:2252-7.
5. Kostler WJ, Tomek S, Brodowicz T, et al. Soluble ICAM-1 in breast cancer: clinical significance and biological implications. Cancer Immunol Immunother 2001;50:483-90.